3.1 NICE has published cancer service guidance improving outcomes in urological cancers.
3.2 NICE has issued interventional procedures guidance on low dose rate brachytherapy for localised prostate cancer, cryotherapy for recurrent prostate cancer, cryotherapy as a primary treatment for prostate cancer, laparoscopic radical prostatectomy and high-intensity focused ultrasound for prostate cancer.
The evidence considered by the interventional procedures advisory committee is described in the interventional procedure overview of high dose rate brachytherapy for prostate cancer.
NICE has produced information for the public on this procedure. It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind.